DEEPVESSEL Plaque
FDA-Cleared AI-Powered Coronary Plaque Analysis
Quantify Plaque. Assess Stenosis. Support Clinical Decision-Making.
DEEPVESSEL Plaque is an FDA-cleared coronary CTA analysis solution that characterizes and quantifies coronary atherosclerotic plaque and stenosis from previously acquired CCTA studies.
Using advanced artificial intelligence and analyst-reviewed workflows, DEEPVESSEL Plaque provides quantitative plaque measurements and visual reports that help clinicians evaluate the presence and extent of coronary artery disease (CAD).
Deep Learning Comprehensive Cardiac Analysis: CT FRR + Plaque Analysis.
DEEPVESSEL Plaque provides anatomical assessment of coronary artery disease through quantitative plaque analysis and stenosis evaluation. Combined with DEEPVESSEL FFR, clinicians can obtain both anatomical and functional assessment from a single coronary CTA examination.
Sign up to stay informed about DVFFR and DV Plaque
Keya Medical - USA
Connect with Keya Medical
DEEPVESSEL Plaque Inquiry
Intended for the U.S. market only. Not for EU promotional use.